VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.2865
-0.0051 (-1.75%)
Jan 16, 2026, 1:09 PM EST - Market open
VolitionRx Employees
VolitionRx had 85 employees as of December 31, 2024. The number of employees decreased by 25 or -22.73% compared to the previous year.
Employees
85
Change (1Y)
-25
Growth (1Y)
-22.73%
Revenue / Employee
$17,318
Profits / Employee
-$269,171
Market Cap
35.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 85 | -25 | -22.73% |
| Dec 31, 2023 | 110 | 6 | 5.77% |
| Dec 31, 2022 | 104 | 21 | 25.30% |
| Dec 31, 2021 | 83 | 18 | 27.69% |
| Dec 31, 2020 | 65 | 15 | 30.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VNRX News
- 4 hours ago - Volition Sponsors Symposium at Veterinary Meeting and Expo - PRNewsWire
- 8 days ago - VolitionRx Secures $2.0 Million in Funding - PRNewsWire
- 8 days ago - VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats - PRNewsWire
- 4 weeks ago - Volition Issues Business Review 2025 - PRNewsWire
- 5 weeks ago - Volition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment - PRNewsWire
- 5 weeks ago - Volition Announces Two Abstracts were Presented at the North America Conference on Lung Cancer - PRNewsWire
- 6 weeks ago - VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis - PRNewsWire
- 7 weeks ago - VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use - PRNewsWire